$1.45
0.010.69%
At Close: -
$1.40
-0.05-3.45%
After Hours: Jul 17, 8:00 AM EDT
15 minutes delayed
Comments
Loading...
Agile Therapeutics
AGRXOTCQB
Agile Therapeutics (OTC:AGRX) Stock, Earnings Estimates, EPS, And Revenue
Agile Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 15
EPS
$-0.630
Quarterly Revenue
$5.7M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$21.5M
Analyze the earnings history of Agile Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGRX | Agile Therapeutics | -$3.10 | — | — | — | $5.50M | — | — | — | 08/07/2024 | Get Alert |
| AGRX | Agile Therapeutics | -$7.76 | -$0.51 | -$0.63 | -23.53% | $3.81M | $3.75M | $5.72M | 52.43% | 05/15/2024 | Get Alert |
| AGRX | Agile Therapeutics | -$9.00 | -$0.92 | -$1.46 | -58.70% | $4.00M | $4.07M | $3.62M | -11.18% | 03/28/2024 | Get Alert |
| AGRX | Agile Therapeutics | -$11.50 | -$1.84 | -$1.47 | 20.11% | $3.00M | $5.27M | $6.66M | 26.41% | 11/09/2023 | Get Alert |
| AGRX | Agile Therapeutics | -$135.50 | -$3.48 | -$3.10 | 10.92% | $2.13M | $4.68M | $5.50M | 17.59% | 08/09/2023 | Get Alert |
| AGRX | Agile Therapeutics | -$189.00 | -$7.50 | -$7.76 | -3.47% | $1.76M | $3.40M | $3.81M | 12.15% | 05/11/2023 | Get Alert |
| AGRX | Agile Therapeutics | -$400.00 | -$11.50 | -$9.00 | 21.74% | $1.51M | $3.08M | $4.00M | 29.74% | 03/22/2023 | Get Alert |
| AGRX | Agile Therapeutics | -$360.00 | -$14.50 | -$11.50 | 20.69% | $1.29M | $2.33M | $3.00M | 28.84% | 11/07/2022 | Get Alert |
| AGRX | Agile Therapeutics | -$400.00 | -$14.50 | -$135.50 | -834.48% | $1.19M | $1.76M | $2.13M | 20.80% | 08/11/2022 | Get Alert |
| AGRX | Agile Therapeutics | -$400.00 | -$240.00 | -$189.00 | 21.25% | $116.00K | $1.22M | $1.76M | 44.34% | 05/12/2022 | Get Alert |
| AGRX | Agile Therapeutics | -$400.00 | -$300.00 | -$400.00 | -33.33% | $749.00K | $1.51M | $1.51M | 0.26% | 03/30/2022 | Get Alert |
| AGRX | Agile Therapeutics | -$360.00 | -$380.00 | -$360.00 | 5.26% | $0.00 | $1.46M | $1.29M | -11.85% | 11/02/2021 | Get Alert |
| AGRX | Agile Therapeutics | -$240.00 | -$420.00 | -$400.00 | 4.76% | $0.00 | $1.95M | $1.19M | -39.23% | 07/26/2021 | Get Alert |
| AGRX | Agile Therapeutics | -$200.00 | -$420.00 | -$400.00 | 4.76% | $0.00 | $600.00K | $116.00K | -80.67% | 05/04/2021 | Get Alert |
| AGRX | Agile Therapeutics | -$200.00 | -$440.00 | -$400.00 | 9.09% | $0.00 | $1.01M | $749.00K | -25.84% | 03/01/2021 | Get Alert |
| AGRX | Agile Therapeutics | -$160.00 | -$360.00 | -$360.00 | 0.00% | $0.00 | — | $0.00 | — | 11/12/2020 | Get Alert |
| AGRX | Agile Therapeutics | -$160.00 | -$280.00 | -$240.00 | 14.29% | $0.00 | — | $0.00 | — | 08/11/2020 | Get Alert |
| AGRX | Agile Therapeutics | -$260.00 | -$180.00 | -$200.00 | -11.11% | $0.00 | — | $0.00 | — | 05/05/2020 | Get Alert |
| AGRX | Agile Therapeutics | -$220.00 | — | -$200.00 | — | $0.00 | — | $0.00 | — | 02/20/2020 | Get Alert |
| AGRX | Agile Therapeutics | -$220.00 | — | -$160.00 | — | $0.00 | — | $0.00 | — | 10/28/2019 | Get Alert |
| AGRX | Agile Therapeutics | -$340.00 | -$220.00 | -$160.00 | 27.27% | $0.00 | — | $0.00 | — | 08/01/2019 | Get Alert |
Agile Therapeutics (AGRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-0.63 | $-0.51 | -23.5 % |
| Dec 2023 | 2024-03-28 | $-1.46 | $-0.92 | -58.7 % |
| Sep 2023 | 2023-11-09 | $-1.47 | $-1.84 | 20.1 % |
| Jun 2023 | 2023-08-09 | $-3.10 | $-3.48 | 10.9 % |
Agile Therapeutics (AGRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $5.72M | $3.75M | 52.4 % |
| Dec 2023 | 2024-03-28 | $3.62M | $4.07M | -11.2 % |
| Sep 2023 | 2023-11-09 | $6.66M | $5.27M | 26.4 % |
| Jun 2023 | 2023-08-09 | $5.50M | $4.68M | 17.6 % |
FAQ
When is Agile Therapeutics (OTCQB:AGRX) reporting earnings?
Agile Therapeutics (AGRX) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Agile Therapeutics (OTCQB:AGRX)?
The Actual EPS was $-0.63, which missed the estimate of $-0.51.
What were Agile Therapeutics’s (OTCQB:AGRX) revenues?
The Actual Revenue was $5.7M, which beat the estimate of $3.8M.
Browse earnings estimates, EPS, and revenue on all stocks.